Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence-Reference-Cited by-同舟云学术

Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence

Published:2017-12 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Bailey Stefanie R.,Nelson Michelle H.^ORCID,Majchrzak Kinga,Bowers Jacob S.,Wyatt Megan M.^ORCID,Smith Aubrey S.,Neal Lillian R.,Shirai Keisuke,Carpenito Carmine,June Carl H.^ORCID,Zilliox Michael J.,Paulos Chrystal M.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01867-9.pdf

Reference61 articles.

1. Topalian, S. L. et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J. Clin. Oncol. 32, 1020–1030 (2014).

2. Pedicord, V. A., Montalvo, W., Leiner, I. M. & Allison, J. P. Single dose of anti-CTLA-4 enhances CD8+ T cell memory formation, function, and maintenance. Proc. Natl Acad. Sci. USA 108, 266–271 (2011).

3. June, C. H. Adoptive T cell therapy for cancer in the clinic. J. Clin. Invest. 117, 1466–1476 (2007).

4. Morgan, R. A. et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J. Immunother. 36, 133–151 (2013).

5. Robbins, P. F. et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917–924 (2011).

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

2. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase;International Journal of Molecular Sciences;2024-09-10

3. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

4. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy;Cancers;2024-06-30

5. Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101;International Journal of Molecular Sciences;2024-06-28